Yorktown Management & Research Company’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,700
| Closed | -$443K | – | 206 |
|
|
2022
Q4 | $443K | Sell |
12,700
-2,620
| -17% | -$91.4K | 0.54% | 64 |
|
|
2022
Q3 | $857K | Hold |
15,320
| – | – | 1.11% | 12 |
|
|
2022
Q2 | $793K | Sell |
15,320
-2,000
| -12% | -$104K | 1.02% | 13 |
|
|
2022
Q1 | $1.26M | Sell |
17,320
-1,980
| -10% | -$144K | 1.07% | 14 |
|
|
2021
Q4 | $2.28M | Buy |
19,300
+1,000
| +5% | +$118K | 1.54% | 6 |
|
|
2021
Q3 | $2.46M | Buy |
18,300
+600
| +3% | +$80.5K | 1.85% | 3 |
|
|
2021
Q2 | $2.87M | Buy |
17,700
+1,700
| +11% | +$275K | 2.25% | 1 |
|
|
2021
Q1 | $1.28M | Buy |
16,000
+1,000
| +7% | +$80.3K | 1.07% | 12 |
|
|
2020
Q4 | $816K | Sell |
15,000
-1,000
| -6% | -$54.4K | 0.73% | 20 |
|
|
2020
Q3 | $318K | Buy |
16,000
+2,800
| +21% | +$55.7K | 0.3% | 181 |
|
|
2020
Q2 | $277K | Buy |
+13,200
| New | +$277K | 0.25% | 217 |
|